 | • レポートコード：QYR9ST03604 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、中枢神経系疾患治療法の世界市場について調査・分析し、中枢神経系疾患治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（うつ病、MS、双極性障害、統合失調症、てんかん、AD、パーキンソン病、その他）、用途別（クリニック、病院）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の中枢神経系疾患治療法市場動向 ・主要企業別マーケットシェア ・中枢神経系疾患治療法の種類別市場規模2014-2019 （うつ病、MS、双極性障害、統合失調症、てんかん、AD、パーキンソン病、その他） ・中枢神経系疾患治療法の用途別市場規模2014-2019 （クリニック、病院） ・中枢神経系疾患治療法の北米市場：主要企業・種類別/用途別市場規模 ・中枢神経系疾患治療法のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・中枢神経系疾患治療法の中国市場：主要企業・種類別/用途別市場規模 ・中枢神経系疾患治療法の日本国内市場：主要企業・種類別/用途別市場規模 ・中枢神経系疾患治療法の東南アジア市場：主要企業・種類別/用途別市場規模 ・中枢神経系疾患治療法のインド市場：主要企業・種類別/用途別市場規模 ・中枢神経系疾患治療法の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Eli Lilly、GlaxoSmithKline、Janssen Pharmaceuticals、Novartis、Pfizer） ・中枢神経系疾患治療法の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both. Depression is the dominated market of CNS Disorders Therapeutics
In 2018, the global Central Nervous System Disorders Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of 3.4% during 2019-2025.
This report focuses on the global Central Nervous System Disorders Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Central Nervous System Disorders Therapeutics development in United States, Europe and China.
The key players covered in this study
Eli Lilly
GlaxoSmithKline
Janssen Pharmaceuticals
Novartis
Pfizer
…
Market segment by Type, the product can be split into
Depression
MS
bipolar disorder
schizophrenia
epilepsy
AD
Parkinson’ s
others
Market segment by Application, split into
Clinicals
Hospitials
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Central Nervous System Disorders Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Central Nervous System Disorders Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Central Nervous System Disorders Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Central Nervous System Disorders Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Depression
1.4.3 MS
1.4.4 bipolar disorder
1.4.5 schizophrenia
1.4.6 epilepsy
1.4.7 AD
1.4.8 Parkinson’ s
1.4.9 others
1.5 Market by Application
1.5.1 Global Central Nervous System Disorders Therapeutics Market Share by Application (2014-2025)
1.5.2 Clinicals
1.5.3 Hospitials
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Central Nervous System Disorders Therapeutics Market Size
2.2 Central Nervous System Disorders Therapeutics Growth Trends by Regions
2.2.1 Central Nervous System Disorders Therapeutics Market Size by Regions (2014-2025)
2.2.2 Central Nervous System Disorders Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Central Nervous System Disorders Therapeutics Market Size by Manufacturers
3.1.1 Global Central Nervous System Disorders Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Central Nervous System Disorders Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Central Nervous System Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Central Nervous System Disorders Therapeutics Key Players Head office and Area Served
3.3 Key Players Central Nervous System Disorders Therapeutics Product/Solution/Service
3.4 Date of Enter into Central Nervous System Disorders Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Central Nervous System Disorders Therapeutics Market Size by Type (2014-2019)
4.2 Global Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Central Nervous System Disorders Therapeutics Market Size (2014-2019)
5.2 Central Nervous System Disorders Therapeutics Key Players in United States
5.3 United States Central Nervous System Disorders Therapeutics Market Size by Type
5.4 United States Central Nervous System Disorders Therapeutics Market Size by Application
6 Europe
6.1 Europe Central Nervous System Disorders Therapeutics Market Size (2014-2019)
6.2 Central Nervous System Disorders Therapeutics Key Players in Europe
6.3 Europe Central Nervous System Disorders Therapeutics Market Size by Type
6.4 Europe Central Nervous System Disorders Therapeutics Market Size by Application
7 China
7.1 China Central Nervous System Disorders Therapeutics Market Size (2014-2019)
7.2 Central Nervous System Disorders Therapeutics Key Players in China
7.3 China Central Nervous System Disorders Therapeutics Market Size by Type
7.4 China Central Nervous System Disorders Therapeutics Market Size by Application
8 Japan
8.1 Japan Central Nervous System Disorders Therapeutics Market Size (2014-2019)
8.2 Central Nervous System Disorders Therapeutics Key Players in Japan
8.3 Japan Central Nervous System Disorders Therapeutics Market Size by Type
8.4 Japan Central Nervous System Disorders Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Central Nervous System Disorders Therapeutics Market Size (2014-2019)
9.2 Central Nervous System Disorders Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Central Nervous System Disorders Therapeutics Market Size by Type
9.4 Southeast Asia Central Nervous System Disorders Therapeutics Market Size by Application
10 India
10.1 India Central Nervous System Disorders Therapeutics Market Size (2014-2019)
10.2 Central Nervous System Disorders Therapeutics Key Players in India
10.3 India Central Nervous System Disorders Therapeutics Market Size by Type
10.4 India Central Nervous System Disorders Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Central Nervous System Disorders Therapeutics Market Size (2014-2019)
11.2 Central Nervous System Disorders Therapeutics Key Players in Central & South America
11.3 Central & South America Central Nervous System Disorders Therapeutics Market Size by Type
11.4 Central & South America Central Nervous System Disorders Therapeutics Market Size by Application
12 International Players Profiles
12.1 Eli Lilly
12.1.1 Eli Lilly Company Details
12.1.2 Company Description and Business Overview
12.1.3 Central Nervous System Disorders Therapeutics Introduction
12.1.4 Eli Lilly Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019)
12.1.5 Eli Lilly Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Company Details
12.2.2 Company Description and Business Overview
12.2.3 Central Nervous System Disorders Therapeutics Introduction
12.2.4 GlaxoSmithKline Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019)
12.2.5 GlaxoSmithKline Recent Development
12.3 Janssen Pharmaceuticals
12.3.1 Janssen Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Central Nervous System Disorders Therapeutics Introduction
12.3.4 Janssen Pharmaceuticals Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019)
12.3.5 Janssen Pharmaceuticals Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Central Nervous System Disorders Therapeutics Introduction
12.4.4 Novartis Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Central Nervous System Disorders Therapeutics Introduction
12.5.4 Pfizer Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019)
12.5.5 Pfizer Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Central Nervous System Disorders Therapeutics Key Market Segments
Table Key Players Central Nervous System Disorders Therapeutics Covered
Table Global Central Nervous System Disorders Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Central Nervous System Disorders Therapeutics Market Size Market Share by Type 2014-2025
Figure Depression Figures
Table Key Players of Depression
Figure MS Figures
Table Key Players of MS
Figure bipolar disorder Figures
Table Key Players of bipolar disorder
Figure schizophrenia Figures
Table Key Players of schizophrenia
Figure epilepsy Figures
Table Key Players of epilepsy
Figure AD Figures
Table Key Players of AD
Figure Parkinson' s Figures
Table Key Players of Parkinson' s
Figure others Figures
Table Key Players of others
Table Global Central Nervous System Disorders Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Clinicals Case Studies
Figure Hospitials Case Studies
Figure Central Nervous System Disorders Therapeutics Report Years Considered
Table Global Central Nervous System Disorders Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Central Nervous System Disorders Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Central Nervous System Disorders Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Central Nervous System Disorders Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Central Nervous System Disorders Therapeutics Market Share by Regions 2014-2019
Figure Global Central Nervous System Disorders Therapeutics Market Share by Regions 2014-2019
Figure Global Central Nervous System Disorders Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Central Nervous System Disorders Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Central Nervous System Disorders Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Central Nervous System Disorders Therapeutics Market Share by Manufacturers in 2018
Table Global Central Nervous System Disorders Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Central Nervous System Disorders Therapeutics Product/Solution/Service
Table Date of Enter into Central Nervous System Disorders Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Central Nervous System Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Central Nervous System Disorders Therapeutics Market Size Share by Type (2014-2019)
Figure Global Central Nervous System Disorders Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Central Nervous System Disorders Therapeutics Market Size Share by Application (2014-2019)
Figure Global Central Nervous System Disorders Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Central Nervous System Disorders Therapeutics Revenue Market Share by Application in 2018
Figure United States Central Nervous System Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Central Nervous System Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Central Nervous System Disorders Therapeutics Market Share (2018-2019)
Table United States Central Nervous System Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Central Nervous System Disorders Therapeutics Market Share by Type (2014-2019)
Table United States Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Central Nervous System Disorders Therapeutics Market Share by Application (2014-2019)
Figure Europe Central Nervous System Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Central Nervous System Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Central Nervous System Disorders Therapeutics Market Share (2018-2019)
Table Europe Central Nervous System Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Central Nervous System Disorders Therapeutics Market Share by Type (2014-2019)
Table Europe Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Central Nervous System Disorders Therapeutics Market Share by Application (2014-2019)
Figure China Central Nervous System Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Central Nervous System Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Central Nervous System Disorders Therapeutics Market Share (2018-2019)
Table China Central Nervous System Disorders Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Central Nervous System Disorders Therapeutics Market Share by Type (2014-2019)
Table China Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Central Nervous System Disorders Therapeutics Market Share by Application (2014-2019)
Figure Japan Central Nervous System Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Central Nervous System Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Central Nervous System Disorders Therapeutics Market Share (2018-2019)
Table Japan Central Nervous System Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Central Nervous System Disorders Therapeutics Market Share by Type (2014-2019)
Table Japan Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Central Nervous System Disorders Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Central Nervous System Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Central Nervous System Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Central Nervous System Disorders Therapeutics Market Share (2018-2019)
Table Southeast Asia Central Nervous System Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Central Nervous System Disorders Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Central Nervous System Disorders Therapeutics Market Share by Application (2014-2019)
Figure India Central Nervous System Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Central Nervous System Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Central Nervous System Disorders Therapeutics Market Share (2018-2019)
Table India Central Nervous System Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Central Nervous System Disorders Therapeutics Market Share by Type (2014-2019)
Table India Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Central Nervous System Disorders Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Central Nervous System Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Central Nervous System Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Central Nervous System Disorders Therapeutics Market Share (2018-2019)
Table Central & South America Central Nervous System Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Central Nervous System Disorders Therapeutics Market Share by Type (2014-2019)
Table Central & South America Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Central Nervous System Disorders Therapeutics Market Share by Application (2014-2019)
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019) (Million US$)
Figure Eli Lilly Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2014-2019)
Table Eli Lilly Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Janssen Pharmaceuticals Company Details
Table Janssen Pharmaceuticals Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019)(Million US$)
Figure Janssen Pharmaceuticals Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2014-2019)
Table Janssen Pharmaceuticals Recent Development
Table Novartis Company Details
Table Novartis Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Global Central Nervous System Disorders Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Central Nervous System Disorders Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Central Nervous System Disorders Therapeutics Market Size Share by Regions in 2025
Figure United States Central Nervous System Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Central Nervous System Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Central Nervous System Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Central Nervous System Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Central Nervous System Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Central Nervous System Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Central Nervous System Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Central Nervous System Disorders Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Central Nervous System Disorders Therapeutics Market Size by Product (2019-2025)
Figure Global Central Nervous System Disorders Therapeutics Market Size by Product in 2025
Table Global Central Nervous System Disorders Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Central Nervous System Disorders Therapeutics Market Size by Application (2019-2025)
Figure Global Central Nervous System Disorders Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の双極性障害治療薬市場：動向・競争分析 Bipolar disorder, also known as manic-depressive disorder, is a combination of manic, hypomanic and depressive episodes.The ultimate goal of therapeutic agents for bipolar disorder is to improve patients' quality of life and maintain good social function as much as possible.The Bipolar Disorder Ther…- 双極性障害治療法の世界市場：市場規模・現状・予測 Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood.The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics. In 2018, the global Bipolar Disorder Therapeu…
- 中枢神経系疾患治薬の世界市場：インサイト・予測 The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord. In this report, we study the drugs for central nervous system disease.The global Central Nervous System Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end…
- 代謝障害治療薬の世界市場：市場規模・現状・予測 Metabolic Disorders Therapeutics is a drug used to treat the symptoms of metabolic disorders caused by a variety of causes.Due to the increasing pressure of modern life and the spread of unhealthy lifestyles, the global metabolic disorder treatment market will continue to grow strongly during the fo…
- 筋骨格障害治療薬の世界市場：市場規模・現状・予測 Musculoskeletal disorders are the group of pain disorders or injuries that affect the body's joints, muscles, nerves, ligaments, tendons, and structures, all of which support the hands, legs, neck and back. The pain and discomfort vary with the severity of the condition. These disorders have a wide …